Regulatory T Cell-Enhancing Therapies to Treat Atherosclerosis
Experimental studies have provided strong evidence that chronic inflammation triggered by the sub-endothelial accumulation of cholesterol-rich lipoproteins in arteries is essential in the initiation and progression of atherosclerosis. Recent clinical trials highlighting the efficacy of anti-inflamma...
Main Authors: | Hafid Ait-Oufella, Jean-Rémi Lavillegrand, Alain Tedgui |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/4/723 |
Similar Items
-
The role of adaptive T cell immunity in atherosclerosis
by: Ziad Mallat, et al.
Published: (2009-01-01) -
Regulatory T Cell Immunity in Atherosclerosis
by: Hilman Zulkifli Amin, et al.
Published: (2017-04-01) -
Adaptive Immune Responses Contribute to Post-ischemic Cardiac Remodeling
by: Icia Santos-Zas, et al.
Published: (2019-01-01) -
Recent Advances on the Role and Therapeutic Potential of Regulatory T Cells in Atherosclerosis
by: Toru Tanaka, et al.
Published: (2021-12-01) -
Regulatory T Cells in Atherosclerosis: Is Adoptive Cell Therapy Possible?
by: Alexey V. Churov, et al.
Published: (2023-09-01)